Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

Dee Luo¹, James A Smith², Nick A Meadows³, Anna Schuh⁴, Katie E Manescu⁵, Kim Bure⁶, Benjamin Davies⁷, Rob Horne⁸, Mike Kope⁹, David L DiGiusto¹⁰, David A Brindley¹¹

Affiliations

¹ Department of Biological Basis of Behavior, University of Pennsylvania Philadelphia, PA, USA.
² The Oxford-University College London Centre for the Advancement of Sustainable Medical Innovation, The University of OxfordOxford, UK; Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of OxfordOxford, UK.
³ Kinapse London, UK.
⁴ Oxford National Institute of Health Research, Biomedical Research Centre, Molecular Diagnostic Centre, Oxford University Hospitals Oxford, UK.
⁵ Department of Biochemical Engineering, University College London London, UK.
⁶ Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford Oxford, UK.
⁷ Sartorius Stedim Göttingen, Germany.
⁸ The UCL School of Pharmacy, University College London London, UK.
⁹ SENS Research Foundation Mountainview, CA, USA.
¹⁰ Stem Cell and Cellular Therapeutics Operations at Stanford University Hospital and Clinic California, CA, USA.
¹¹ Department of Biological Basis of Behavior, University of PennsylvaniaPhiladelphia, PA, USA; The Oxford-University College London Centre for the Advancement of Sustainable Medical Innovation, The University of OxfordOxford, UK; Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of OxfordOxford, UK; USCF-Stanford Center of Excellence in Regulatory Science and InnovationCalifornia, CA, USA; Centre for Behavioural Medicine, UCL School of Pharmacy, University College LondonLondon, UK; Harvard Stem Cell InstituteCambridge, MA, USA.

PMID: 27375679
PMCID: PMC4894887
DOI: 10.3389/fgene.2016.00104

Published Erratum

Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

Dee Luo et al. Front Genet. 2016.

. 2016 Jun 7:7:104.

doi: 10.3389/fgene.2016.00104. eCollection 2016.

Authors

Dee Luo¹, James A Smith², Nick A Meadows³, Anna Schuh⁴, Katie E Manescu⁵, Kim Bure⁶, Benjamin Davies⁷, Rob Horne⁸, Mike Kope⁹, David L DiGiusto¹⁰, David A Brindley¹¹

Affiliations

¹ Department of Biological Basis of Behavior, University of Pennsylvania Philadelphia, PA, USA.
² The Oxford-University College London Centre for the Advancement of Sustainable Medical Innovation, The University of OxfordOxford, UK; Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of OxfordOxford, UK.
³ Kinapse London, UK.
⁴ Oxford National Institute of Health Research, Biomedical Research Centre, Molecular Diagnostic Centre, Oxford University Hospitals Oxford, UK.
⁵ Department of Biochemical Engineering, University College London London, UK.
⁶ Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford Oxford, UK.
⁷ Sartorius Stedim Göttingen, Germany.
⁸ The UCL School of Pharmacy, University College London London, UK.
⁹ SENS Research Foundation Mountainview, CA, USA.
¹⁰ Stem Cell and Cellular Therapeutics Operations at Stanford University Hospital and Clinic California, CA, USA.
¹¹ Department of Biological Basis of Behavior, University of PennsylvaniaPhiladelphia, PA, USA; The Oxford-University College London Centre for the Advancement of Sustainable Medical Innovation, The University of OxfordOxford, UK; Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of OxfordOxford, UK; USCF-Stanford Center of Excellence in Regulatory Science and InnovationCalifornia, CA, USA; Centre for Behavioural Medicine, UCL School of Pharmacy, University College LondonLondon, UK; Harvard Stem Cell InstituteCambridge, MA, USA.

PMID: 27375679
PMCID: PMC4894887
DOI: 10.3389/fgene.2016.00104

Abstract

[This corrects the article on p. 357 in vol. 6, PMID: 26858745.].

Keywords: combinational therapy; commercialization; companion diagnostic; healthcare risk management; healthcare translation; personalized medicine; risk:benefit appraisal; stratified medicine.

PubMed Disclaimer

Figures

**Figure 3**
**Significant relationships and non-significant relationships for CDx price. (A)** There is a significant relationship between CDx price and CDx sensitivity (R² = −0.10, p = 0.04). **(B)** There are non-significant relationships between CDx price and drug price (R² = 0.043, p = 0.70) and **(C)** the total patient population (R² = 0.105 p = 0.59).

See this image and copyright information in PMC

Erratum for

A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics.
Luo D, Smith JA, Meadows NA, Schuh A, Manescu KE, Bure K, Davies B, Horne R, Kope M, DiGiusto DL, Brindley DA. Luo D, et al. Front Genet. 2016 Jan 28;6:357. doi: 10.3389/fgene.2015.00357. eCollection 2015. Front Genet. 2016. PMID: 26858745 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

Affiliations

Corrigendum: A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

Authors

Affiliations

Abstract

Figures

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources